Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, G-Protein-Coupled | 3 | 2019 | 1205 | 0.730 |
Why?
|
Lactates | 1 | 2019 | 405 | 0.680 |
Why?
|
Primary Graft Dysfunction | 1 | 2017 | 100 | 0.610 |
Why?
|
Thrombotic Microangiopathies | 1 | 2017 | 126 | 0.580 |
Why?
|
Kidney Failure, Chronic | 3 | 2017 | 2544 | 0.480 |
Why?
|
Kidney Diseases | 3 | 2006 | 2097 | 0.390 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 486 | 0.380 |
Why?
|
Macrophage Activation | 1 | 2013 | 583 | 0.380 |
Why?
|
Kidney Transplantation | 6 | 2017 | 4138 | 0.340 |
Why?
|
Proteinuria | 3 | 2005 | 625 | 0.280 |
Why?
|
Sepsis | 1 | 2019 | 2463 | 0.270 |
Why?
|
Kidney Tubules, Proximal | 2 | 2006 | 416 | 0.260 |
Why?
|
Uric Acid | 2 | 2010 | 739 | 0.260 |
Why?
|
Antiporters | 3 | 2009 | 263 | 0.230 |
Why?
|
Renin-Angiotensin System | 2 | 2005 | 761 | 0.210 |
Why?
|
Albuminuria | 1 | 2005 | 673 | 0.200 |
Why?
|
Biological Transport, Active | 2 | 2013 | 354 | 0.190 |
Why?
|
Macrophages | 2 | 2013 | 5746 | 0.190 |
Why?
|
Gout | 1 | 2006 | 539 | 0.180 |
Why?
|
Fetus | 1 | 2006 | 1853 | 0.170 |
Why?
|
Chloride-Bicarbonate Antiporters | 2 | 2009 | 99 | 0.160 |
Why?
|
Hypertension | 3 | 2006 | 8270 | 0.160 |
Why?
|
Glomerular Filtration Rate | 1 | 2005 | 2101 | 0.160 |
Why?
|
Anion Transport Proteins | 2 | 2009 | 141 | 0.150 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2016 | 78 | 0.150 |
Why?
|
Bone Remodeling | 1 | 2017 | 588 | 0.120 |
Why?
|
Osteoclasts | 1 | 2017 | 733 | 0.120 |
Why?
|
Immediate-Early Proteins | 1 | 2016 | 457 | 0.120 |
Why?
|
NF-kappa B | 2 | 2013 | 2556 | 0.120 |
Why?
|
Niacin | 1 | 2013 | 115 | 0.110 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 2 | 2011 | 165 | 0.110 |
Why?
|
Pyrimethamine | 1 | 2011 | 95 | 0.100 |
Why?
|
Sodium | 1 | 2016 | 1600 | 0.100 |
Why?
|
Mineral Oil | 1 | 2010 | 22 | 0.100 |
Why?
|
Chemotaxis | 1 | 2013 | 614 | 0.100 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 652 | 0.090 |
Why?
|
Interleukins | 1 | 2013 | 799 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9838 | 0.080 |
Why?
|
Brain Death | 2 | 2001 | 305 | 0.080 |
Why?
|
Animals | 18 | 2019 | 169173 | 0.080 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 888 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2019 | 15040 | 0.080 |
Why?
|
Sodium Channels | 1 | 2009 | 359 | 0.080 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 404 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2113 | 0.070 |
Why?
|
Xenopus laevis | 4 | 2016 | 1011 | 0.070 |
Why?
|
Organic Cation Transport Proteins | 1 | 2006 | 55 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2010 | 569 | 0.070 |
Why?
|
Ischemia | 2 | 2010 | 1904 | 0.070 |
Why?
|
Symporters | 2 | 2005 | 365 | 0.070 |
Why?
|
Organic Anion Transporters | 1 | 2006 | 89 | 0.070 |
Why?
|
Eels | 1 | 2005 | 9 | 0.070 |
Why?
|
Sequence Homology | 1 | 2006 | 205 | 0.070 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2005 | 70 | 0.070 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2005 | 67 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2246 | 0.070 |
Why?
|
Fresh Water | 1 | 2005 | 75 | 0.070 |
Why?
|
Nephrons | 1 | 2006 | 197 | 0.070 |
Why?
|
Acid-Base Equilibrium | 1 | 2005 | 184 | 0.070 |
Why?
|
Oocytes | 4 | 2016 | 1217 | 0.070 |
Why?
|
Receptors, Dopamine D1 | 1 | 2006 | 295 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 13209 | 0.060 |
Why?
|
Sulfates | 1 | 2005 | 382 | 0.060 |
Why?
|
Mice | 7 | 2019 | 80270 | 0.060 |
Why?
|
Disease Progression | 3 | 2005 | 13219 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 349 | 0.060 |
Why?
|
Acidosis | 1 | 2005 | 273 | 0.060 |
Why?
|
Kidney Glomerulus | 1 | 2006 | 690 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4449 | 0.060 |
Why?
|
Bicarbonates | 3 | 2009 | 311 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 464 | 0.060 |
Why?
|
Up-Regulation | 2 | 2010 | 4303 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2005 | 396 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 11098 | 0.050 |
Why?
|
Patch-Clamp Techniques | 3 | 2009 | 968 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 852 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6654 | 0.050 |
Why?
|
Acetaminophen | 1 | 2005 | 547 | 0.050 |
Why?
|
Kidney | 4 | 2011 | 6855 | 0.050 |
Why?
|
Chronic Disease | 2 | 2006 | 9028 | 0.050 |
Why?
|
Hyperlipidemias | 1 | 2005 | 803 | 0.050 |
Why?
|
Chlorides | 3 | 2009 | 674 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1482 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2010 | 2708 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2016 | 2089 | 0.040 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2000 | 335 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2017 | 96 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2005 | 6572 | 0.040 |
Why?
|
RNA, Messenger | 6 | 2016 | 13203 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 16726 | 0.040 |
Why?
|
Rats, Wistar | 2 | 2016 | 1954 | 0.040 |
Why?
|
Humans | 15 | 2017 | 715594 | 0.040 |
Why?
|
Cyclosporine | 1 | 1999 | 816 | 0.040 |
Why?
|
Anemia | 1 | 2005 | 1421 | 0.040 |
Why?
|
Isoantibodies | 1 | 1999 | 666 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2055 | 0.030 |
Why?
|
Graft Survival | 2 | 2010 | 3753 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3032 | 0.030 |
Why?
|
Rats | 6 | 2016 | 24794 | 0.030 |
Why?
|
Rats, Inbred Lew | 3 | 2001 | 1171 | 0.030 |
Why?
|
Homeostasis | 1 | 2005 | 3328 | 0.030 |
Why?
|
Smoking Cessation | 1 | 2005 | 2011 | 0.030 |
Why?
|
Serotonin | 1 | 2017 | 1032 | 0.030 |
Why?
|
Tissue Distribution | 2 | 2009 | 2397 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 1999 | 1058 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2006 | 5098 | 0.030 |
Why?
|
Aminosalicylic Acids | 1 | 2011 | 38 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 2009 | 4438 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2010 | 62039 | 0.030 |
Why?
|
Benzenesulfonates | 1 | 2011 | 173 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 2011 | 471 | 0.020 |
Why?
|
Transplantation, Isogeneic | 2 | 2001 | 280 | 0.020 |
Why?
|
Tissue Donors | 1 | 2000 | 2152 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2009 | 3959 | 0.020 |
Why?
|
Maryland | 1 | 2010 | 277 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 433 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 2030 | 0.020 |
Why?
|
Pancreas | 1 | 2016 | 1684 | 0.020 |
Why?
|
Gene Expression | 3 | 2011 | 7944 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2009 | 3843 | 0.020 |
Why?
|
DNA Primers | 2 | 2005 | 2974 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2010 | 395 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 577 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 337 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1999 | 3816 | 0.020 |
Why?
|
Smoking | 1 | 2005 | 8950 | 0.020 |
Why?
|
Signal Transduction | 1 | 2011 | 23705 | 0.020 |
Why?
|
Chemokine CCL2 | 2 | 2000 | 653 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 1602 | 0.020 |
Why?
|
G-Protein-Coupled Receptor Kinase 4 | 1 | 2006 | 3 | 0.020 |
Why?
|
G-Protein-Coupled Receptor Kinases | 1 | 2006 | 4 | 0.020 |
Why?
|
Cysts | 1 | 2011 | 636 | 0.020 |
Why?
|
RNA, Complementary | 1 | 2005 | 46 | 0.020 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2006 | 57 | 0.020 |
Why?
|
Heparin Antagonists | 1 | 2006 | 36 | 0.020 |
Why?
|
Mesna | 1 | 2005 | 69 | 0.020 |
Why?
|
Cytokines | 1 | 2001 | 7190 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1351 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 24776 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2000 | 1171 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 2839 | 0.020 |
Why?
|
Biotinylation | 1 | 2005 | 184 | 0.020 |
Why?
|
Ifosfamide | 1 | 2005 | 221 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 2006 | 292 | 0.020 |
Why?
|
Seawater | 1 | 2005 | 109 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 2998 | 0.020 |
Why?
|
Ion Transport | 1 | 2006 | 327 | 0.020 |
Why?
|
Proline | 1 | 2005 | 437 | 0.020 |
Why?
|
Etoposide | 1 | 2005 | 628 | 0.020 |
Why?
|
Codon | 1 | 2005 | 609 | 0.020 |
Why?
|
Inflammation | 2 | 2001 | 10090 | 0.020 |
Why?
|
Cytarabine | 1 | 2005 | 689 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 2006 | 352 | 0.010 |
Why?
|
Candidiasis | 1 | 2005 | 360 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3286 | 0.010 |
Why?
|
Obesity | 1 | 2005 | 12268 | 0.010 |
Why?
|
Cation Transport Proteins | 1 | 2005 | 328 | 0.010 |
Why?
|
Glycine | 1 | 2005 | 690 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2005 | 18583 | 0.010 |
Why?
|
Lymphoma, Follicular | 1 | 2005 | 420 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 19892 | 0.010 |
Why?
|
Stomach | 1 | 2006 | 667 | 0.010 |
Why?
|
Biological Transport | 1 | 2005 | 2119 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 2919 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1625 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6631 | 0.010 |
Why?
|
Neutropenia | 1 | 2005 | 877 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1878 | 0.010 |
Why?
|
Reoperation | 1 | 2010 | 4177 | 0.010 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2005 | 612 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8647 | 0.010 |
Why?
|
Protein Transport | 1 | 2006 | 2051 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2005 | 1110 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1999 | 393 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2006 | 11664 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5859 | 0.010 |
Why?
|
Heparin | 1 | 2006 | 1620 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2005 | 1307 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 718 | 0.010 |
Why?
|
Fever | 1 | 2005 | 1586 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5369 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2009 | 3630 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2000 | 1264 | 0.010 |
Why?
|
Protein Binding | 1 | 2009 | 9555 | 0.010 |
Why?
|
Graft Rejection | 1 | 2010 | 4395 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2009 | 5109 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 16559 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4285 | 0.010 |
Why?
|
Intestines | 1 | 2006 | 1918 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 1298 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3879 | 0.010 |
Why?
|
Creatinine | 1 | 2001 | 1888 | 0.010 |
Why?
|
Nephrectomy | 1 | 2000 | 1004 | 0.010 |
Why?
|
Male | 6 | 2016 | 350143 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 13171 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15185 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4887 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 14154 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2000 | 1973 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18175 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10285 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 22636 | 0.010 |
Why?
|
Adult | 3 | 2011 | 212237 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9810 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39334 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40889 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8525 | 0.010 |
Why?
|
Female | 3 | 2010 | 377052 | 0.000 |
Why?
|
Neurons | 1 | 2005 | 9371 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1999 | 4192 | 0.000 |
Why?
|
Blood Pressure | 1 | 2001 | 8534 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11238 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2010 | 72448 | 0.000 |
Why?
|
Mutation | 1 | 2005 | 29253 | 0.000 |
Why?
|
Middle Aged | 1 | 2010 | 214639 | 0.000 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_